Novel compounds designed to allow interactions with binding sites of GSK-3 and hence are capable of inhibiting GSK-3 activity, via inhibition of substrate binding are disclosed. Further disclosed are pharmaceutical compositions including same and methods of using same in the treatment of GSK-3 mediated conditions.

 
Web www.patentalert.com

< Processes for preparing 6-alkyl-5-arylsulfonyl-dihydrophenanthridines

> Azacyclic ethynyl derivatives

~ 00436